Skip to main content

Satsuma Pharmaceuticals, Inc.

STSADelisted Jun 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001692830

Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Satsuma Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of STSA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6045−15
Shares23.8M23.2M−525.5K (−2.2%)
Value$167.4M$108.3M−$59.2M (−35.3%)

New holders (4)

Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to STSA in Q3 2021
InstitutionSharesValue% of portfolio
Nan Fung Group Holdings Ltd142,900$666.0K0.21%
Chicago Partners Investment Group LLC11,150$68.0K0.00%
Schonfeld Strategic Advisors LLC14,200$67.0K0.00%
ClariVest Asset Management LLC612$3.00K0.00%

Sold out (19)

Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of STSA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Monashee Investment Management LLC118,027$832.0K
Marshall Wace, LLP70,247$495.0K
Ergoteles LLC42,000$296.0K
Tibra Equities Europe Ltd35,000$247.0K
JPMorgan Chase & Co21,707$153.0K
Deutsche Bank AG20,840$147.0K
Bailard, Inc.20,500$145.0K
First Trust Advisors LP20,012$141.0K
Jane Street Group, LLC19,257$136.0K
Jump Financial, LLC18,700$132.0K
Parametric Portfolio Associates LLC16,921$119.0K
Winton Group Ltd13,955$98.0K
ExodusPoint Capital Management, LP13,474$95.0K
UBS Group AG3,005$21.0K
Bank of America Corp1,903$13.0K
Royal Bank of Canada1,774$13.0K
Captrust Financial Advisors128$1.00K
New York State Common Retirement Fund63$0
Citigroup Inc1$0